S. 127 · 118th Congress · Health

Pharmacy Benefit Manager Transparency Act of 2023

Died in the Senate7.1k words Introduced Jan 26, 2023 · Latest action Dec 13, 2023

How far it has goneStopped at 3 of 6 · Died in the Senate
  1. IntroducedJan 26, 2023 Done
  2. CommitteeReported Dec 13, 2023 Done
  3. Senate floorDied Jan 3, 2025 Stopped here
  4. House floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

This bill generally prohibits pharmacy benefit managers (PBMs) from engaging in certain practices when managing the prescription drug benefits under a health insurance plan, including charging the plan a different amount than the PBM reimburses the pharmacy.

The bill also prohibits PBMs from arbitrarily, unfairly, or deceptively (1) clawing back reimbursement payments, or (2) increasing fees or lowering reimbursements to pharmacies to offset changes to federally funded health plans.

PBMs are not subject to these prohibitions if they (1) pass along 100% of any price concession or discount to the health plan, and (2) disclose specified costs, prices, reimbursements, fees, markups, discounts, and aggregate payments received with respect to their PBM services.

Further, PBMs must report annually to the Federal Trade Commission (FTC) certain information about payments received from health plans and fees charged to pharmacies.

The FTC and state attorneys general are authorized to enforce the provisions of the bill.

Congressional Research Service · summary of “Introduced in Senate” version · Jan 26, 2023

Who lobbies on it

54 organizations · 398 filings · Q1 2023–Q4 2024

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. Chamber of Commerce of the U.s.a. 8 of 8 quarters
    “H.R. 1264, Commonsense Reporting Act of 2023 H.R. 2813, Self-Insurance Protection Act H.R. 2868, Association Health Plans Act H.R. 3800, Chronic Disease Flexible Coverage Act H.R. 4307/S. 2115, Medical Supply Chain Resiliency Act H.R. 6363, Further Continuing Appropriations and Other Extensions Act of 2024, and issues…”

    Q4 2024 filing · $74.5M lobbying spend in 2024, all issues

  2. Pharmaceutical Research and Manufacturers of America 8 of 8 quarters
    “H.R. 198: Drug Pricing Transparency and Accountability Act - Provisions related to the 340B Program H.R. 456: Fairness in Orphan Drug Exclusivity Act H.R. 830: HELP Copays Act - To amend title XXVII of the Public Health Service Act to apply additional payments, discounts, and other financial assistance towards the…”

    Q4 2024 filing · $31.0M lobbying spend in 2024, all issues

  3. American Medical Association 8 of 8 quarters
    “H.R. 618, Improving Access to Workers Compensation for Injured Federal Workers Act, all provisions S. 131, Improving Access to Workers Compensation for Injured Federal Workers Act, all provisions H.R. 2923, Living Donor Protection Act, all provisions of 2023, all provisions S. 1384, Living Donor Protection Act, all…”

    Q4 2024 filing · $24.3M lobbying spend in 2024, all issues

51 more organizations, every filingPROUpgrade

Organizations that named S. 127 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.

Actions

5 actions · newest first
  1. Dec 13, 2023Placed on Senate Legislative Calendar under General Orders. Calendar No. 283.
  2. Dec 13, 2023Committee on Commerce, Science, and Transportation. Reported by Senator Cantwell with an amendment in the nature of a substitute. Without written report.
  3. Mar 22, 2023Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.
  4. Jan 26, 2023Read twice and referred to the Committee on Commerce, Science, and Transportation.
Show all 5 actionsShow fewer
  1. Jan 26, 2023Introduced in Senate